159 related articles for article (PubMed ID: 28179311)
1. Telomere Length and Risk of Hepatocellular Carcinoma: A Nested Case-control Study in Taiwan Cancer Screening Program Cohort.
Zeng H; Wu HC; Wang Q; Yang HI; Chen CJ; Santella RM; Shen J
Anticancer Res; 2017 Feb; 37(2):637-644. PubMed ID: 28179311
[TBL] [Abstract][Full Text] [Related]
2. Leucocytes telomere length and breast cancer risk/ susceptibility: A case-control study.
Pavanello S; Varesco L; Gismondi V; Bruzzi P; Bolognesi C
PLoS One; 2018; 13(5):e0197522. PubMed ID: 29782524
[TBL] [Abstract][Full Text] [Related]
3. Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma.
Ma Q; Cai J; Cai Y; Xu Y; Chang F; Xu L; Zhang G; Guo X
Medicine (Baltimore); 2016 Sep; 95(39):e4970. PubMed ID: 27684844
[TBL] [Abstract][Full Text] [Related]
4. Paired assessment of liver telomere lengths in hepatocellular cancer is a reliable predictor of disease persistence.
Feng W; Yu D; Li B; Luo OY; Xu T; Cao Y; Ding Y
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28108675
[TBL] [Abstract][Full Text] [Related]
5. Relative telomere length: a novel non-invasive biomarker for the risk of non-cirrhotic hepatocellular carcinoma in patients with chronic hepatitis B infection.
Fu X; Wan S; Hann HW; Myers RE; Hann RS; Au J; Chen B; Xing J; Yang H
Eur J Cancer; 2012 May; 48(7):1014-22. PubMed ID: 22444598
[TBL] [Abstract][Full Text] [Related]
6. Telomere length variation in tumor cells and cancer-associated fibroblasts: potential biomarker for hepatocellular carcinoma.
Ma LJ; Wang XY; Duan M; Liu LZ; Shi JY; Dong LQ; Yang LX; Wang ZC; Ding ZB; Ke AW; Cao Y; Zhang XM; Zhou J; Fan J; Gao Q
J Pathol; 2017 Dec; 243(4):407-417. PubMed ID: 28833123
[TBL] [Abstract][Full Text] [Related]
7. Telomere length in peripheral blood leukocytes is associated with risk of colorectal cancer in Chinese population.
Qin Q; Sun J; Yin J; Liu L; Chen J; Zhang Y; Li T; Shi Y; Wei S; Nie S
PLoS One; 2014; 9(2):e88135. PubMed ID: 24498432
[TBL] [Abstract][Full Text] [Related]
8. Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases.
Martinez-Delgado B; Yanowsky K; Inglada-Perez L; de la Hoya M; Caldes T; Vega A; Blanco A; Martin T; Gonzalez-Sarmiento R; Blasco M; Robledo M; Urioste M; Song H; Pharoah P; Benitez J
J Med Genet; 2012 May; 49(5):341-4. PubMed ID: 22493152
[TBL] [Abstract][Full Text] [Related]
9. Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease.
Donati B; Pietrelli A; Pingitore P; Dongiovanni P; Caddeo A; Walker L; Baselli G; Pelusi S; Rosso C; Vanni E; Daly A; Mancina RM; Grieco A; Miele L; Grimaudo S; Craxi A; Petta S; De Luca L; Maier S; Soardo G; Bugianesi E; Colli F; Romagnoli R; Anstee QM; Reeves HL; Fracanzani AL; Fargion S; Romeo S; Valenti L
Cancer Med; 2017 Aug; 6(8):1930-1940. PubMed ID: 28677271
[TBL] [Abstract][Full Text] [Related]
10. Longer leukocyte telomere length predicts increased risk of hepatitis B virus-related hepatocellular carcinoma: a case-control analysis.
Liu J; Yang Y; Zhang H; Zhao S; Liu H; Ge N; Yang H; Xing JL; Chen Z
Cancer; 2011 Sep; 117(18):4247-56. PubMed ID: 21387275
[TBL] [Abstract][Full Text] [Related]
11. Genetic association of telomere length with hepatocellular carcinoma risk: A Mendelian randomization analysis.
Cheng Y; Yu C; Huang M; Du F; Song C; Ma Z; Zhai X; Yang Y; Liu J; Bei JX; Jia W; Jin G; Li S; Zhou W; Liu J; Dai J; Hu Z
Cancer Epidemiol; 2017 Oct; 50(Pt A):39-45. PubMed ID: 28797893
[TBL] [Abstract][Full Text] [Related]
12. Correlates of telomere length shortening in peripheral leukocytes of HIV-infected individuals and association with leukoaraiosis.
Minami R; Takahama S; Yamamoto M
PLoS One; 2019; 14(6):e0218996. PubMed ID: 31246986
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of C-reactive protein increase susceptibility to HBV-related hepatocellular carcinoma in a Guangxi male population.
Lao X; Ren S; Lu Y; Yang D; Qin X; Li S
Int J Clin Exp Pathol; 2015; 8(12):16055-63. PubMed ID: 26884882
[TBL] [Abstract][Full Text] [Related]
14. Alterations of telomere length and mtDNA copy number are associated with overall survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Bao D; Ba Y; Zhou F; Zhao J; Yang Q; Ge N; Guo X; Wu Z; Zhang H; Yang H; Wan S; Xing J
Cancer Chemother Pharmacol; 2016 Oct; 78(4):791-9. PubMed ID: 27558242
[TBL] [Abstract][Full Text] [Related]
15. Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients.
Wan S; Hann HW; Ye Z; Hann RS; Lai Y; Wang C; Li L; Myers RE; Li B; Xing J; Yang H
Carcinogenesis; 2017 Apr; 38(4):439-446. PubMed ID: 28334112
[TBL] [Abstract][Full Text] [Related]
16. The Contribution of Matrix Metalloproteinase-1 Genotypes to Hepatocellular Carcinoma Susceptibility in Taiwan.
Lai YL; Gong CL; Fu CK; Yueh TC; Tsai CW; Chang WS; Hsiao CL; Yen ST; Li HT; Jeng LB; Wang SC; Bau DT
Cancer Genomics Proteomics; 2017; 14(2):119-125. PubMed ID: 28387651
[TBL] [Abstract][Full Text] [Related]
17. U-shaped association between telomere length and esophageal squamous cell carcinoma risk: a case-control study in Chinese population.
Du J; Xue W; Ji Y; Zhu X; Gu Y; Zhu M; Wang C; Gao Y; Dai J; Ma H; Jiang Y; Chen J; Hu Z; Jin G; Shen H
Front Med; 2015 Dec; 9(4):478-86. PubMed ID: 26581417
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma.
Lee HW; Park TI; Jang SY; Park SY; Park WJ; Jung SJ; Lee JH
Medicine (Baltimore); 2017 Feb; 96(5):e5766. PubMed ID: 28151853
[TBL] [Abstract][Full Text] [Related]
19. TIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women.
Tsai HT; Hsieh MJ; Chiou HL; Lee HL; Hsin MC; Liou YS; Yang CC; Yang SF; Kuo WH
Tumour Biol; 2014 Sep; 35(9):8999-9007. PubMed ID: 24903383
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serum DNA integrity as a screening and prognostic tool in patients with hepatitis C virus-related hepatocellular carcinoma.
El-Shazly SF; Eid MA; El-Sourogy HA; Attia GF; Ezzat SA
Int J Biol Markers; 2010; 25(2):79-86. PubMed ID: 20544686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
